SAUHY:OTC-Straumann Holding AG ADR (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 12.85

Change

-0.08 (-0.62)%

Market Cap

USD 24.28B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ESLOF EssilorLuxottica Société ano..

+1.23 (+0.54%)

USD 103.48B
ESLOY Essilor International SA

+1.48 (+1.32%)

USD 102.35B
HOCPY Hoya Corp

-1.09 (-0.89%)

USD 44.03B
HOCPF HOYA Corporation

-2.99 (-2.37%)

USD 43.50B
RSMDF Resmed Inc DRC

N/A

USD 31.41B
CLPBF Coloplast A/S

+1.94 (+1.59%)

USD 27.31B
TRUMF Terumo Corporation

-1.05 (-5.74%)

USD 25.91B
TRUMY Terumo Corp ADR

-0.34 (-1.92%)

USD 25.10B
SRTOY Sartorius Stedim Biotech S.A

-3.15 (-13.04%)

USD 22.04B
SDMHF Sartorius Stedim Biotech S.A

N/A

USD 21.72B

ETFs Containing SAUHY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.21% 26% F 24% F
Dividend Return 0.55% 41% F 11% F
Total Return -19.66% 25% F 24% F
Trailing 12 Months  
Capital Gain -19.21% 42% F 44% F
Dividend Return 0.56% 24% F 6% D-
Total Return -18.65% 42% F 42% F
Trailing 5 Years  
Capital Gain 54.45% 79% B- 82% B
Dividend Return 3.71% 12% F 12% F
Total Return 58.16% 79% B- 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 21.80% 72% C 67% D+
Dividend Return 22.24% 68% D+ 64% D
Total Return 0.44% 32% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 42.79% 57% F 56% F
Risk Adjusted Return 51.97% 91% A- 88% B+
Market Capitalization 24.28B 87% B+ 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.